CM
IDXX icon

Capula Management’s Idexx Laboratories IDXX Stock Holding History

Capula Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$169K Buy
300
+100
+50% +$64.1K ﹤0.01% 793
2025
Q4 		$135K Buy
+200
New +$136K ﹤0.01% 669

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capula Management's IDXX Position: Q1 2026 in Review

Capula Management opened a new position in Idexx Laboratories (IDXX) in Q1 2026: 111 shares worth $62.4K. The stake represents ﹤0.01% of the portfolio and ranks #965 among its holdings. This is a return to the name: Capula Management previously reported a position in IDXX as recently as Q2 2023.

Capula Management first reported a position in IDXX in Q2 2021 and has held it in 6 quarters since. The position peaked at $945K in Q3 2022. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Capula Management held 111 shares of Idexx Laboratories worth $62.4K as of Q1 2026.
  • Idexx Laboratories was a new Capula Management position in Q1 2026.
  • Idexx Laboratories made up ﹤0.01% of Capula Management's portfolio in Q1 2026, its #965 holding.
  • Capula Management first reported a position in Idexx Laboratories in Q2 2021 and has held it in 6 quarters since.
  • Capula Management's Idexx Laboratories position peaked at $945K in Q3 2022.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Capula Management's 13F filing for Q1 2026, filed 14 May 2026.